Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Q: What does CUSIP 03168L105 represent in this 13F holders report?

CUSIP 03168L105 is the security identifier for AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 used to aggregate holder disclosures.

Q: How many institutions held AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in Q3 2024?

180 institutional investors reported AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 03168L105

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Class A Common Stock, par value $0.01
Shares outstanding: 315,976,000
Total 13F shares: 142,604,811
Share change: +3,241,628
Total reported value: $1,186,537,394
Put/Call ratio: 86%
Price per share: $8.32
Number of holders: 180
Value change: +$32,304,784
Number of buys: 88
Number of sells: 81

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2024

As of 30 Sep 2024, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 180 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 142,604,811 shares. The largest 10 holders included UBS Group AG, VANGUARD GROUP INC, BlackRock, Inc., TPG GP A, LLC, Rubric Capital Management LP, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, NEUBERGER BERMAN GROUP LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 180 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.